Related Experiment Video

Updated: Oct 8, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.3K

The year in cardiovascular medicine 2021: interventional cardiology

Javier Escaned1, Farouc A Jaffer2, Julinda Mehilli3

  • 1Hospital Clínico San Carlos IDISCC, Complutense University of Madrid, Madrid, Spain.

European Heart Journal
|January 2, 2022
PubMed

Insights

Interventional cardiology has advanced significantly, covering percutaneous coronary intervention (PCI) and structural heart interventions. This review highlights progress despite the ongoing challenges posed by the COVID-19 pandemic.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Innovation

Background:

  • The practice of interventional cardiology has continued amidst the global COVID-19 pandemic.
  • Healthcare professionals face significant burdens due to the ongoing pandemic.
  • Previous reports have established a benchmark for yearly progress.

Purpose of the Study:

  • To review and summarize recent advancements in interventional cardiology.
  • To provide an update on developments in percutaneous coronary intervention (PCI).
  • To cover progress in structural heart interventions and adjunctive pharmacotherapy.

Main Methods:

  • Yearly review of developments in interventional cardiology.
  • Analysis of progress in percutaneous coronary intervention (PCI).
  • Assessment of advancements in structural heart interventions and pharmacotherapy.

Main Results:

  • Substantial progress has been observed across all areas of interventional cardiology.
  • Developments in PCI techniques and devices continue.
  • Innovations in structural heart interventions and pharmacotherapy are notable.

Conclusions:

  • Interventional cardiology has seen significant advancements over the past year.
  • Progress in PCI and structural heart interventions continues despite pandemic challenges.
  • Adjunctive pharmacotherapy plays a crucial role in supporting interventional procedures.

Keywords:
Antiplatelet agentsCoronary interventionsInterventional cardiologyTranscatheter aortic valve implantation

More Related Videos

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

1.2K
Author Spotlight: Advancements in Intracardiac Echocardiography for Atrial Anatomy Assessment04:29

Author Spotlight: Advancements in Intracardiac Echocardiography for Atrial Anatomy Assessment

Published on: June 30, 2023

1.1K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
59
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.4K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
236
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
295
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60